Skip to main content

Nuclear Medicine Methods in Scrotal Imaging

  • Chapter
Scrotal Pathology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

Abstract

In patients with acute scrotal pain scrotal scintigraphy can be used to exclude torsion of the testicle, which presents with unilateral decrease in activity on the affected side.The role of nuclear medicine methods, however, faded in the last years after the introduction of high performance color Doppler ultrasound equipment. Lymphoscintigraphy can be used in patients with testicular cancer to demonstrate the lymphatic drainage pathway of the neoplasm. Several studies suggest that 18FDG-PET/CT might have a role in the staging germ cell tumors, in identification of recurrent/residual disease, to monitor the treatment response and during the follow-up. Other investigations, however, did not confirm these results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albers P, Bender H, Yilmaz H et al (1999) Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 53:808–811

    Article  PubMed  CAS  Google Scholar 

  • Aso C, Enriquez G, Fite M et al (2005) Gray-scale and color Doppler sonography of scrotal disorders in children: an update. Radiographics 25:1197–1214

    Article  PubMed  Google Scholar 

  • Bekerman C, Hoffer PB, Bitran JD (1984) The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 14:296–323

    Article  PubMed  CAS  Google Scholar 

  • Cremerius U, Effert PJ, Adam G et al (1998) FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 39:815–822

    PubMed  CAS  Google Scholar 

  • Cremerius U, Wildberger JE, Borchers H et al (1999) Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients. Urology 54:900–904

    Article  PubMed  CAS  Google Scholar 

  • De Santis M, Bokemeyer C, Becherer A et al (2001) Predictive impact of 2–18fluoro-2-deoxy-d-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 19:3740–3744

    PubMed  Google Scholar 

  • De Santis M, Becherer A, Bokemeyer C et al (2004) 2–18fluoro-deoxy-d-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22:1034–1039

    Article  PubMed  Google Scholar 

  • Goldfarb LR, Alazraki NP, Eshima D, et al (1998) Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99 m sulfur colloid. Radiology, 208:505–509

    Google Scholar 

  • Hain SF, O’Doherty MJ, Timothy AR et al (2000a) Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 27:590–594

    Article  PubMed  CAS  Google Scholar 

  • Hain SF, O’Doherty MJ, Timothy AR et al (2000b) Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83:863–869

    Article  PubMed  CAS  Google Scholar 

  • Hinz S, Schrader M, Kempkensteffen C et al (2008) The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 179:936–940 discussion 940

    Article  PubMed  Google Scholar 

  • Jackson FI, Dierich HC, Lentle BC (1976) Gallium-67 citrate scintiscanning in testicular neoplasia. J Can Assoc Radiol 27:84–88

    PubMed  CAS  Google Scholar 

  • MacDonald A, Burrell S (2009) Infrequently performed studies in nuclear medicine: part 2. J Nucl Med Technol 37:1–13

    Article  PubMed  Google Scholar 

  • Nadel NS, Gitter MH, Hahn LC et al (1973) Preoperative diagnosis of testicular torsion. Urology 1:478–479

    Article  PubMed  CAS  Google Scholar 

  • Nuutinen JM, Leskinen S, Elomaa I et al (1997) Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 33:1234–1241

    Article  PubMed  CAS  Google Scholar 

  • Oechsle K, Hartmann M, Brenner W et al (2008) [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 26:5930–5935

    Article  PubMed  Google Scholar 

  • Paltiel HJ, Connolly LP, Atala A et al (1998) Acute scrotal symptoms in boys with an indeterminate clinical presentation: comparison of color Doppler sonography and scintigraphy. Radiology 207:223–231

    PubMed  CAS  Google Scholar 

  • Paterson AH, Peckham MJ, McCready VR (1976) Value of gallium scanning in seminoma of the testis. Br Med J 1:1118–1121

    Article  PubMed  CAS  Google Scholar 

  • Sauerbrunn BJ, Andrews GA, Hubner KF (1978) Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study. J Nucl Med 19:470–475

    PubMed  CAS  Google Scholar 

  • Spermon JR, De Geus-Oei LF, Kiemeney LA et al (2002) The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89:549–556

    Article  PubMed  CAS  Google Scholar 

  • Stephens AW, Gonin R, Hutchins GD et al (1996) Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 14:1637–1641

    PubMed  CAS  Google Scholar 

  • Stomper PC, Kalish LA, Garnick MB et al (1991) CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 180:711–714

    PubMed  CAS  Google Scholar 

  • Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623–648 discussion 649-650

    PubMed  CAS  Google Scholar 

  • Sugawara Y, Zasadny KR, Grossman HB et al (1999) Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology 211:249–256

    PubMed  CAS  Google Scholar 

  • Symmonds RE, Tauxe WN (1972) Gallium-67 scintigraphy of gynecologic tumors. Am J Obstet Gynecol 114:356–369

    PubMed  CAS  Google Scholar 

  • Tanis PJ, Horenblas S, Valdes Olmos RA et al (2002) Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging 29:670–673

    Article  PubMed  Google Scholar 

  • Toner GC, Panicek DM, Heelan RT et al (1990) Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8:1683–1694

    PubMed  CAS  Google Scholar 

  • Tsatalpas P, Beuthien-Baumann B, Kropp J et al (2002) Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors. Urol Int 68:157–163

    Article  PubMed  Google Scholar 

  • Uchiyama M, Kantoff PW, Kaplan WD (1994) Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings. J Nucl Med 35:1624–1630

    PubMed  CAS  Google Scholar 

  • Warren GP, Einhorn LH (1995) Gallium scans in the evaluation of residual masses after chemotherapy for seminoma. J Clin Oncol 13:2784–2788

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors thank Vincenzo Allegri, Valentina Ambrosini and Stefano Fanti of the Department of Nuclear Medicine, S. Orsola Malpighi Hospital, Bologna, for their contribution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Caruso .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Caruso, G., Salvaggio, G., Asabella, A.N., Carluccio, S., Rubini, G. (2011). Nuclear Medicine Methods in Scrotal Imaging. In: Bertolotto, M., Trombetta, C. (eds) Scrotal Pathology. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_198

Download citation

  • DOI: https://doi.org/10.1007/174_2011_198

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-12455-6

  • Online ISBN: 978-3-642-12456-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics